Friday, March 15, 2013

An Antioxidant May Prevent Neuron Loss In Schizophrenia And Depression

Gamma-aminobutyric acid (GABA) deficits have been implicated in schizophrenia and depression. In schizophrenia, deficits have been particularly well-described for a subtype of GABA neuron, the parvalbumin fast-spiking interneurons. The activity of these neurons is critical for proper cognitive and emotional functioning...

URL: http://www.medicalnewstoday.com/releases/257652.php

No comments:

Post a Comment